Octagon Capital Advisors LP / XLRN
Octagon Capital Advisors LP’s Acceleron Pharma Inc Position
Does Octagon Capital Advisors LP own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 112.4K shares worth $14M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$14M
Q2 2021
Shares
112.4K
% of Portfolio
+2.92%
Quarters Held
3
position exited
Position History XLRN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of XLRN.